- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05116670
Comparison of Care Practices, Mortality and Morbidity of Very Preterm Infants Between Two Tertiary Centers in Northwest and South of China
February 14, 2022 updated by: Zhangbin Yu, Nanjing Medical University
Care practices, mortality and morbidity of very premature infants from two different tertiary centers were collected and compared, in order to discover areas for improvement where these two newborn centers can learn from each other.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This retrospective cohort study was conducted in two hospitals,Qinghai Red Cross Hospital and Jinan University affiliated Shenzhen Baoan Women's and Children's Hospital.Very premature infants born with a gestational age between 22+0 - 31+6 weeks admitted to both centers during 3 years from January 1, 2018 to December 31, 2020 were studied.
In both centers, data including maternal characteristics, neonatal characteristics, obstetric practices, delivery room practices, and neonatal outcomes, were collected by data abstractors in each NICU.
Anonymous data was transferred to Shenzhen and analyses were performed at the newborn center of SZH.
Study Type
Observational
Enrollment (Actual)
807
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Shenzhen, Guangdong, China, 518000
- Shenzhen Baoan Women's and Children's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 day to 4 weeks (Child)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Very premature infants born with a gestational age between 22+0 - 31+6 weeks admitted to newborn centers of Qinghai Red Cross Hospital and Shenzhen Baoan Women's and Children's Hospital from Jan 1, 2018 to Dec 31, 2020.
Description
Inclusion Criteria:
- Very premature infants born with a gestational age between 22+0 - 31+6 weeks;
- Admitted to both centers during 3 years from January 1, 2018 to December 31, 2020.
Exclusion Criteria:
- Infants not born at QHH or SZH (out born);
- Infants who had major congenital anomalies;
- Infants admitted after 7 days of life.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Qinghai Red Cross Hospital
|
|
Shenzhen Baoan Women's and Children's Hospital
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
mortality
Time Frame: Jan 1,2018 - Dec 31,2020
|
death during hospitalisation and death after withdrawing treatment
|
Jan 1,2018 - Dec 31,2020
|
|
Major morbidity
Time Frame: Jan 1,2018 - Dec 31,2020
|
severe neurological injury, moderate to severe BPD, NEC or severe ROP
|
Jan 1,2018 - Dec 31,2020
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 15, 2021
Primary Completion (Actual)
December 31, 2021
Study Completion (Actual)
December 31, 2021
Study Registration Dates
First Submitted
October 31, 2021
First Submitted That Met QC Criteria
October 31, 2021
First Posted (Actual)
November 11, 2021
Study Record Updates
Last Update Posted (Actual)
March 3, 2022
Last Update Submitted That Met QC Criteria
February 14, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NMU-FY2021-58
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Morbidity;Newborn
-
Assumpta Solome NantumeDLR German Aerospace Center; Academic Model Providing Access to Healthcare...RecruitingNewborn Morbidity | Newborn ComplicationKenya
-
Universidad Autonoma de Nuevo LeonCompletedHospital Readmission | Newborn Morbidity | Newborn | Newborn Complication
-
University of Alabama at BirminghamCompletedNewborn MorbidityUnited States
-
Julie LefevereCompletedNewborn MorbidityBelgium
-
Konya City HospitalCompleted
-
Hacettepe UniversityCompletedSurgery--Complications | Newborn Morbidity | Neonatal SurgeryTurkey
-
Universidad de la SabanaCompletedTelemedicine | Newborn Morbidity | Simulation Training | Assessment, SelfColombia
-
Aga Khan UniversityBill and Melinda Gates FoundationCompleted
-
The Cleveland ClinicAmerican Academy of PediatricsCompletedFailure to Thrive | Newborn MorbidityUnited States
-
Hillel Yaffe Medical CenterUnknownNewborn MorbidityIsrael